⌘K

Home/Filings/4/0000950170-25-044346

4//SEC Filing

Baker Daniel G. 4

Accession 0000950170-25-044346

CIK 0001645460other

View on SEC.gov Company Profile

Filed

Mar 24, 8:00 PM ET

Accepted

Mar 25, 4:00 PM ET

Size

5.3 KB

Accession

0000950170-25-044346

Insider Transaction Report

Form 4

Period: 2025-03-21

Cue Biopharma, Inc.CUE

Baker Daniel G.

CHIEF DEVELOPMENT OFFICER

Transactions

Award
Stock Option (right to buy)
2025-03-21+100,000→ 100,000 total
Exercise: $0.99Exp: 2035-03-20→ Common Stock (100,000 underlying)

Footnotes (1)

[F1]This stock option becomes exercisable in eight equal semi-annual installments beginning on September 21, 2025.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1

filerCIK 0002046802

Filing Metadata

Form type: 4
Filed: Mar 24, 8:00 PM ET
Accepted: Mar 25, 4:00 PM ET
Size: 5.3 KB

View on SEC.gov